Bozilenko Marina's most recent trade in Talphera Inc. was a trade of 30,700 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Talphera Inc | Marina S. Bozilenko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2026 | 30,700 | 30,700 | - | - | Stock Option (Right to Buy) | |
| Talphera Inc | Marina S. Bozilenko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2026 | 5,100 | 14,147 (0%) | 0% | 0 | Common Stock | |
| Talphera Inc | Marina S. Bozilenko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2025 | 25,600 | 25,600 | - | - | Stock Option (Right to Buy) | |
| Talphera Inc | Marina S. Bozilenko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2025 | 4,267 | 9,047 (0%) | 0% | 0 | Common Stock | |
| Talphera Inc | Marina Bozilenko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 13,044 | 13,044 | - | - | Stock Option (Right to Buy) | |
| Talphera Inc | Marina Bozilenko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 2,174 | 4,780 (0%) | 0% | 0 | Common Stock | |
| Acelrx Pharma Inc | Bozilenko Marina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2023 | 3,487 | 3,487 | - | - | Stock Option (Right to Buy) | |
| Acelrx Pharma Inc | Bozilenko Marina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2023 | 581 | 2,606 (0%) | 0% | 0 | Common Stock |